Looking for Parabolic Growth? Hexo Stock Is a Winner

Here’s why I think Hexo (TSX:HEXO)(NYSE:HEXO) is an intriguing domestic cannabis play for investors bullish on the growth this sector can provide long term.

| More on:
Money growing in soil , Business success concept.

Image source: Getty Images

Following Canadian legalization in 2018, the cannabis industry has been flourishing in the country. This sector did take a breather in recent quarters but has resumed its red-hot rise of late. Indeed, Canadian investors are once again riding the wave. Many are now looking for the best options to put their money to work.

Here’s why I think Hexo (TSX:HEXO)(NYSE:HEXO) could be a great pick for those looking to do so.

HEXO continues to outperform

The cannabis industry has remained a growing contributor to Canada’s GDP. Indeed, this sector generated approximately $8.65 billion for the country’s economy in May 2020. That’s an impressive number, considering the 11% year-over-year growth. The Canadian government thus has an incentive to support this sector now. Hexo, being one of the largest names in this sector, could therefore do very well for long-term investors.

However, despite legalization, this sector mainly suffered from structural and organizational issues, and the company had a rough 2020. But Hexo has also seemingly turned things around in the right direction.

In Q1, Hexo’s revenue doubled year over year. To be precise, shares returned 102%, comfortably beating predictions of the broader index. In the Q4 earnings call held in Dec. 2020, this company reported year-over-year growth of 8.7% on its quarterly sales, standing at $29.4 million.

In Q4 FY2020, Hexo reported a negative gross margin of 121%. By Q1 2020, the trend reversed, and HEXO managed to break even in gross margins.

The domestic market had a significant role to play

Right now, much of the excitement in cannabis stocks is over U.S. legalization. And rightfully so — it’s a massive catalyst. However, Hexo’s domestic performance of late is worth noting for fundamental long-term investors.

Indeed, the vast majority of Hexo’s sales have been in the domestic Canadian market. This company is the largest in the Quebec province in terms of sales, a trend that I think is not likely to change anytime soon. As we have seen with other industries, the Quebec government highly supports its local businesses and heavily invests in maintaining supply chains.

With the local market predicted to grow, I expect Hexo will continue to meet its capital targets, making it an intriguing investment option. While it does not have significant exposure to the U.S. market, if Hexo upholds a bullish trend in the domestic market, it could retain its impressive revenue growth going into the future.

Bottom line

Hexo’s market cap, as of writing, is $1.174 billion, with a steep price/sales ratio of 12.26. However, out of all the cannabis producers listed in Canada, my two top picks right now are Curaleaf and Hexo. Analysts predict that Hexo will post robust revenue projections, increasing sales by 73.1% year over year in 2021. I think these stocks have intriguing upside now, and for those inclined to invest in cannabis, these can be the perfect stocks to get a head-start.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any of the stocks mentioned. The Motley Fool recommends HEXO. and HEXO.

More on Cannabis Stocks

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Are Cannabis Stocks Still a Thing in 2023?

The whole question of whether cannabis stocks are still relevant in 2023 is an interesting one. Here's my take on…

Read more »

A cannabis plant grows.
Cannabis Stocks

Why Canopy Growth Stock Fell 72% Last Year

Canopy Growth stock is a beaten-up cannabis giant that is trading at a discount compared to historical multiples. But is…

Read more »